Patent ID: 11945787
Assignee: ELA PHARMA LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The method of claim 1, wherein the subject suffers from cellular necrosis of a cell as a result of a disease or condition selected from the group consisting of acute tubular necrosis, alcoholism, aseptic necrosis, asphyxia, Anderson's disease, avascular necrosis, celiac disease, chemotherapy induced necrosis, cirrhosis, Crohn's disease, cystic fibrosis, degenerative arthritis, diabetes mellitus, endometriosis, gangrene, glomerulonephritis, hemoglobinuria, hepatitis, hyperthermia, impairment of transplant tissue, ischemic heart disease, leukemia, lymphoma, macular degeneration, muscular dystrophy, myocardial infarction, necrotizing fasciitis, neonatal respiratory distress, nephrotoxicity, osteomyelitis, pancreatitis, phenylketonuria, psoriasis, radiation induced necrosis, reduced quality of transplant tissue, renal cortical necrosis, retinal necrosis, rheumatoid arthritis, sepsis, spinal cord injury, Stevens-Johnson syndrome, syphilis, tuberculosis, tyrosemia, vascular dystrophy, a bacterial infection, a burn, a cerebrovascular damage, a cerebrovascular disease, a cold injury, a compartment syndrome, a complication of steroid treatment, a congenital mitochondrial disease, a fungal infection, an incarcerated hernia, an iron-load complication, a metabolic inherited disease, a necrosis associated with administration with or exposure to an agrochemical, a necrosis associated with administration with or exposure to a chemical toxin, a necrosis associated with a dermal filler administration, a necrosis associated with administration with or exposure to a drug, a necrosis associated with an ectopic drug administration, a necrosis associated with administration with or exposure to a heavy metal, a necrosis associated with administration with or exposure to a snake venom, a necrosis associated with administration with or exposure to a spider venom, a necrosis associated with administration with or exposure to a warfare organophosphate, a necrotizing procolitis, a neurodegenerative disease, a parasitic infection, a placental infarct, a pressure sore, a reperfusion injury, a toxic epidermal necrosis, and a viral infection.